Haifeng Huang is regularly called on to lead teams and advise clients on their complex disputes and intellectual property matters. He has a broad practice covering disputes and transactions involving patents, trademarks, copyrights, trade secrets, unfair competition, antitrust, and technology licenses. The WTR 1000 described him as "one of the country's most seasoned litigators, with a history of representing large U.S. and Chinese concerns in high-stakes disputes."
Haifeng has advised clients on cases in many courts and agencies throughout China and elsewhere, as well as before multiple arbitration tribunals. These cases have involved a diverse range of industries, including software and systems, semiconductors, microelectronics, telecommunications, textiles, chemicals, optics, consumer products, heavy machinery, pharmaceuticals, medical devices, and biotechnology.
He also manages due diligence and transactions and negotiates agreements involving the acquisition, license, and commercialization of intellectual property assets, including R&D collaboration, sponsored research, joint development, clinical trials, cross-licensing, strategic alliance, manufacturing, distribution, consulting, and software services.
Haifeng's extensive experience has received significant recognition, including being named a "WIPR Leader" by World IP Review and selected as an "IP Star" by Managing Intellectual Property. He was also endorsed by peers and clients as a "strategic, very reliable and trustworthy" name and having a "top-notch IP practice" in China in Chambers Global (2020-2021).
- October 19, 2021
Trade Secret Enforcement in Greater China: Past Data and Recent Developments
- October 7, 2021
Protection of Trademarks and Intellectual Property in China
- July 21, 2021
How to Protect Your Innovative Drugs Under China's Hatch-Waxman Act
- January 18, 2016
Fee Shifting Strategies for Patent Troll Litigation and IP Review in M&A Transactions
- October 25, 2012
China Inbound Seminar: New Challenges and Opportunities for Foreign Investments in China
- October 23, 2012
Life Science Legal Drama - "Mr. Big in Wonderland"
- May 16, 2012
Demystifying Well-known Mark Recognition in China
- April 13, 2012
Strategies of Defending Trade Secret Lawsuits in China and the US
- February 13, 2012
Ten Common Mistakes to Avoid while Protecting Your IP Rights in China
- September 21, 2011
Managing Intellectual Property in China - Realities and Pitfalls
- September 9, 2011
Arbitration Clauses in Commercial Agreements - Do you know what you're signing up to?
- April 16, 2011
Walking on Eggshells: Dealing with IP and Regulatory Issues in China
- April 6, 2011
IP Due Diligence
- November 23, 2010
Technology Transfer in China
- November 22, 2010
Protecting Your Brands in China: Challenges and Opportunities
- April 25, 2008
Regulatory Roadmap for Pharmaceutical Innovations in China
"Haifeng Huang is very practical, down to earth and persistent in resolving clients' issues. He is detail oriented and has 100% success rates for the disputes he handled for us."The Legal 500 Asia Pacific
- Harvard University (LL.M. 2003); Renmin University of China (LL.D. 2006; LL.M. 2001; LL.B. 1998; Founding Editor, Law Review; Executive Editor, Chinese Intellectual Property Review)
- New York (USA) and Hong Kong
2016-2017 Global Fellow, Federal Circuit Bar Association
Regularly recommended in Chambers Asia-Pacific and The Legal 500 Asia Pacific for intellectual property
IAM Patent (2016): "Carved a niche on the Chinese litigation scene, routinely appearing in must-win infringement and invalidation battles"
Managing Intellectual Property (2015): "Consistently delivered favorable results ... his guidance is practical and strategic, and takes into account the nuances of the Chinese system"
- English, Mandarin